"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 5 | 5 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 14 | 14 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 17 | 17 |
| 2008 | 0 | 12 | 12 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 20 | 20 |
| 2011 | 0 | 27 | 27 |
| 2012 | 0 | 27 | 27 |
| 2013 | 1 | 33 | 34 |
| 2014 | 0 | 38 | 38 |
| 2015 | 0 | 44 | 44 |
| 2016 | 0 | 43 | 43 |
| 2017 | 2 | 47 | 49 |
| 2018 | 0 | 45 | 45 |
| 2019 | 0 | 46 | 46 |
| 2020 | 0 | 49 | 49 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 19 | 19 |
| 2023 | 1 | 6 | 7 |
| 2024 | 0 | 11 | 11 |
| 2025 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
The impact of a geriatric assessment-guided management intervention (GAIN-S) on prognostic awareness: A randomized controlled trial. Cancer. 2025 Sep 01; 131(17):e70054.
-
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025 Aug 01; 5(8):1288-1297.
-
P53-Induced Autophagy Degradation of NKX3-2 Improves Ovarian Cancer Prognosis. Cells. 2025 05 22; 14(11).
-
Explainable transformer-based deep survival analysis in childhood acute lymphoblastic leukemia. Comput Biol Med. 2025 Jun; 191:110118.
-
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes. Leukemia. 2025 Apr; 39(4):942-950.
-
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
-
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study. Leukemia. 2025 Mar; 39(3):710-719.
-
Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor? Clin Ter. 2025 Jan-Feb; 176(1):52-59.
-
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 2024 Oct 20; 13(20).